Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2012

01-10-2012 | Editorial

Ways forward to identify new ACPA targets in RA

Authors: A Jimmy Ytterberg, Vivianne Malmström

Published in: Arthritis Research & Therapy | Issue 5/2012

Login to get access

Abstract

Anti-citrullinated protein antibodies (ACPAs) of the IgG subtype have become a critical hallmark of HLA-associated rheumatoid arthritis (RA) and point to important contributions from the adaptive immune system. To dissect the contributing autoimmune reactions, investigators must not only identify the protein targets of ACPA but also define the precise peptides recognized by the immune system. Several possible approaches could be used to achieve this goal, and sensitive mass spectrometry of relevant tissue is a promising way forward in advancing our detailed understanding of autoimmune immune reactions involved in RA pathogenesis.
Literature
1.
go back to reference Raijmakers R, van Beers JJ, El-Azzouny M, Visser NF, Bozic B, Pruijn GJ, Heck AJ: Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther. 2012, 14: R114-10.1186/ar3840.PubMedCentralCrossRefPubMed Raijmakers R, van Beers JJ, El-Azzouny M, Visser NF, Bozic B, Pruijn GJ, Heck AJ: Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther. 2012, 14: R114-10.1186/ar3840.PubMedCentralCrossRefPubMed
2.
go back to reference Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003, 171: 538-541.CrossRefPubMed Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003, 171: 538-541.CrossRefPubMed
3.
go back to reference Snir O, Rieck M, Gebe JA, Yue BB, Rawlings CA, Nepom G, Malmström V, Buckner JH: Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 2011, 63: 2873-2883. 10.1002/art.30445.PubMedCentralCrossRefPubMed Snir O, Rieck M, Gebe JA, Yue BB, Rawlings CA, Nepom G, Malmström V, Buckner JH: Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis Rheum. 2011, 63: 2873-2883. 10.1002/art.30445.PubMedCentralCrossRefPubMed
4.
go back to reference Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L: Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011, 23: 92-98. 10.1016/j.smim.2011.01.014.CrossRefPubMed Klareskog L, Malmström V, Lundberg K, Padyukov L, Alfredsson L: Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol. 2011, 23: 92-98. 10.1016/j.smim.2011.01.014.CrossRefPubMed
5.
go back to reference Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, Catrina AI: Citrullination is an inflammation-dependent process. Ann Rheum Dis. 2006, 65: 1219-1222. 10.1136/ard.2005.049403.PubMedCentralCrossRefPubMed Makrygiannakis D, af Klint E, Lundberg IE, Lofberg R, Ulfgren AK, Klareskog L, Catrina AI: Citrullination is an inflammation-dependent process. Ann Rheum Dis. 2006, 65: 1219-1222. 10.1136/ard.2005.049403.PubMedCentralCrossRefPubMed
6.
go back to reference Bae S, Kim H, Lee N, Won C, KIm HR, Hwang YI, Song YW, Kang JS, Lee WJ: alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol. 2012, 189: 365-372. 10.4049/jimmunol.1102073.CrossRefPubMed Bae S, Kim H, Lee N, Won C, KIm HR, Hwang YI, Song YW, Kang JS, Lee WJ: alpha-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol. 2012, 189: 365-372. 10.4049/jimmunol.1102073.CrossRefPubMed
7.
go back to reference Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G: Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012, 122: 1791-1802. 10.1172/JCI60975.PubMedCentralCrossRefPubMed Harre U, Georgess D, Bang H, Bozec A, Axmann R, Ossipova E, Jakobsson PJ, Baum W, Nimmerjahn F, Szarka E, Sarmay G, Krumbholz G, Neumann E, Toes R, Scherer HU, Catrina AI, Klareskog L, Jurdic P, Schett G: Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest. 2012, 122: 1791-1802. 10.1172/JCI60975.PubMedCentralCrossRefPubMed
8.
go back to reference De Ceuleneer M, Van Steendam K, Dhaenens M, Deforce D: vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics. 2012, 12: 752-760. 10.1002/pmic.201100478.CrossRefPubMed De Ceuleneer M, Van Steendam K, Dhaenens M, Deforce D: vivo relevance of citrullinated proteins and the challenges in their detection. Proteomics. 2012, 12: 752-760. 10.1002/pmic.201100478.CrossRefPubMed
9.
go back to reference Hermansson M, Artemenko K, Ossipova E, Eriksson H, Lengqvist J, Makrygiannakis D, Catrina AI, Nicholas AP, Klareskog L, Savitski M, Zubarev RA, Jakobsson PJ: MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl. 2010, 4: 511-518.PubMed Hermansson M, Artemenko K, Ossipova E, Eriksson H, Lengqvist J, Makrygiannakis D, Catrina AI, Nicholas AP, Klareskog L, Savitski M, Zubarev RA, Jakobsson PJ: MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen. Proteomics Clin Appl. 2010, 4: 511-518.PubMed
10.
go back to reference Ytterberg AJ, Reynisdottir G, Ossipova E, Rutishauser D, Hensvold A, Eklund A, Sköld M, Grunewald J, Lundberg K, Malmström V, Jakobsson PJ, Zubarev RA, Klareskog L, Catrina AI: Identification of shared immunological targets in the lungs and joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2012, 71: A19-CrossRef Ytterberg AJ, Reynisdottir G, Ossipova E, Rutishauser D, Hensvold A, Eklund A, Sköld M, Grunewald J, Lundberg K, Malmström V, Jakobsson PJ, Zubarev RA, Klareskog L, Catrina AI: Identification of shared immunological targets in the lungs and joints of patients with rheumatoid arthritis. Ann Rheum Dis. 2012, 71: A19-CrossRef
Metadata
Title
Ways forward to identify new ACPA targets in RA
Authors
A Jimmy Ytterberg
Vivianne Malmström
Publication date
01-10-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4031

Other articles of this Issue 5/2012

Arthritis Research & Therapy 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.